<DOC>
	<DOCNO>NCT00536705</DOCNO>
	<brief_summary>The Objective research observe effect cysteinyl leukotriene receptor antagonist expression variation TGF-β1 level mRNA expression child mild persistent asthma plasma T lymphocyte , discuss role TGF-β1 pathogenesis bronchial asthma child evaluate function regulation leukotriene receptor antagonist asthma child .</brief_summary>
	<brief_title>Effect Montelukast Expression Variation TGF-β Children With Mild Persistent Asthma</brief_title>
	<detailed_description>The majority pediatric asthma patient Shanghai mild persistent asthma . These patient require controller medication every day achieve maintain control . Leukotriene receptor antagonist one option recommend use mono controller therapy . Patient satisfaction compliance well montelukast , attribute oral intake convenience . Owing easy simple oral day administration montelukast find advantageous ICS . On hand , recent study show considerable degree airway remodel peripheral airway patient mild asthma.The new information point need large , long term study treatment mild persistent asthma , emphasis exacerbation , remodel , relationship outcome marker asthma control . TGF-β participates initiation propagation inflammatory immune response airway . The leukotrienes exert biologic action bind activate specific receptor . Montelukast , cysteinyl leukotriene 1 ( CysLT1 ) receptor antagonist , act LTC4 , LTD4 LTE4 , , therefore , airway inflammation bronchoconstriction . Some result suggest low dose Montelukast may modulate parameter inflammation fibrosis.In study try determine effect low dose Montelukast expression variation TGF-β induce sputum T lymphocyte child mild persistent Asthma . Drug study provide MSD . We do induce sputum procedure past study . Reagent buy company .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patients age 6 14 year history physiciandiagnosed asthma ( least 3 episode asthma symptom previous year , include , limited cough , wheeze , shortness breath ) Patients good health , asthma , basis result medical history , physical examination , routine laboratory test .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>asthma</keyword>
	<keyword>child</keyword>
	<keyword>transform growth factor beta ( TGF-β )</keyword>
	<keyword>Leukotriene Antagonists ( Montelukast )</keyword>
</DOC>